IBDEI1C8 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22740,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,22741,0)
 ;;=M86.60^^87^983^61
 ;;^UTILITY(U,$J,358.3,22741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22741,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,22741,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,22741,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,22742,0)
 ;;=M86.40^^87^983^56
 ;;^UTILITY(U,$J,358.3,22742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22742,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,22742,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,22742,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,22743,0)
 ;;=R50.2^^87^983^23
 ;;^UTILITY(U,$J,358.3,22743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22743,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,22743,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,22743,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,22744,0)
 ;;=R50.9^^87^983^27
 ;;^UTILITY(U,$J,358.3,22744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22744,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,22744,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,22744,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,22745,0)
 ;;=R76.11^^87^983^1
 ;;^UTILITY(U,$J,358.3,22745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22745,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,22745,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,22745,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,22746,0)
 ;;=Z21.^^87^983^30
 ;;^UTILITY(U,$J,358.3,22746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22746,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,22746,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,22746,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,22747,0)
 ;;=B37.0^^87^983^16
 ;;^UTILITY(U,$J,358.3,22747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22747,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,22747,1,4,0)
 ;;=4^B37.0
 ;;^UTILITY(U,$J,358.3,22747,2)
 ;;=^5000612
 ;;^UTILITY(U,$J,358.3,22748,0)
 ;;=B97.10^^87^983^22
 ;;^UTILITY(U,$J,358.3,22748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22748,1,3,0)
 ;;=3^Enterovirus,Unspec,as Cause of Disease
 ;;^UTILITY(U,$J,358.3,22748,1,4,0)
 ;;=4^B97.10
 ;;^UTILITY(U,$J,358.3,22748,2)
 ;;=^5000861
 ;;^UTILITY(U,$J,358.3,22749,0)
 ;;=R50.82^^87^983^24
 ;;^UTILITY(U,$J,358.3,22749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22749,1,3,0)
 ;;=3^Fever,Postprocedural
 ;;^UTILITY(U,$J,358.3,22749,1,4,0)
 ;;=4^R50.82
 ;;^UTILITY(U,$J,358.3,22749,2)
 ;;=^5019509
 ;;^UTILITY(U,$J,358.3,22750,0)
 ;;=R50.83^^87^983^26
 ;;^UTILITY(U,$J,358.3,22750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22750,1,3,0)
 ;;=3^Fever,Postvaccination
 ;;^UTILITY(U,$J,358.3,22750,1,4,0)
 ;;=4^R50.83
 ;;^UTILITY(U,$J,358.3,22750,2)
 ;;=^5019510
 ;;^UTILITY(U,$J,358.3,22751,0)
 ;;=R50.84^^87^983^25
 ;;^UTILITY(U,$J,358.3,22751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22751,1,3,0)
 ;;=3^Fever,Posttransfusion
 ;;^UTILITY(U,$J,358.3,22751,1,4,0)
 ;;=4^R50.84
 ;;^UTILITY(U,$J,358.3,22751,2)
 ;;=^5019511
 ;;^UTILITY(U,$J,358.3,22752,0)
 ;;=B02.23^^87^983^70
 ;;^UTILITY(U,$J,358.3,22752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22752,1,3,0)
 ;;=3^Postherpetic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,22752,1,4,0)
 ;;=4^B02.23
 ;;^UTILITY(U,$J,358.3,22752,2)
 ;;=^266550
 ;;^UTILITY(U,$J,358.3,22753,0)
 ;;=B02.22^^87^983^71
 ;;^UTILITY(U,$J,358.3,22753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22753,1,3,0)
 ;;=3^Postherpetic Trigeminal Neuralgia
 ;;^UTILITY(U,$J,358.3,22753,1,4,0)
 ;;=4^B02.22
 ;;^UTILITY(U,$J,358.3,22753,2)
 ;;=^266546
